Press release
Presbyopia Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies - Eyenovia, Orasis Pharmaceutical, Ocuphire Pharma, Novartis, Visus Therapeutics
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Presbyopia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Presbyopia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Presbyopia Market Insights https://www.delveinsight.com/report-store/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Presbyopia Overview
According to American Academy of Opthalmology, Presbyopia is a normal part of aging wherein your eyes gradually lose the ability to see things clearly up close. The term "presbyopia" comes from a Greek word which means "old eye." Most people begin to notice the effect of presbyopia sometime after the age of 40 as the lenses of the eyes naturally lose their elasticity due to the aging process.
Some of the key facts of the Presbyopia Market Report:
• The Presbyopia market size was valued at USD 17,883 Million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to the American Optometric Association though Presbyopia usually becomes visible in the early to mid-40s, but the reduction in the vision of an individuals' focus starts as early as childhood
• The total prevalent cases of Presbyopia in the 7MM was found to be approximately 289,136,235 cases in 2021. These cases are expected to increase by 2032
• The United States had the highest prevalent cases of Presbyopia with approximately 118,346,762 cases in 2021
• Key Presbyopia Companies: Eyenovia, Orasis Pharmaceutical, Ocuphire Pharma, Novartis, Visus Therapeutics, and others
• Key Presbyopia Therapies: MicroLine, CSF-1, Nyxol, UNR844, VT-101, Brimochol, and others
• The Presbyopia epidemiology based on gender analyzed that the prevalence of Presbyopia is higher in females than males
Get a Free sample for the Presbyopia Market Report
https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Key benefits of the Presbyopia Market report:
1. Presbyopia market report covers a descriptive overview and comprehensive insight of the Presbyopia Epidemiology and Presbyopia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Presbyopia market report provides insights on the current and emerging therapies.
3. Presbyopia market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Presbyopia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Presbyopia market.
Download the report to understand which factors are driving Presbyopia epidemiology trends @ Presbyopia Epidemiological Insights
https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Presbyopia Market
The dynamics of the Presbyopia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
"The pipeline for Presbyopia is dynamic, consisting of Orasis Pharmaceuticals (PresbiDrops), Novartis (UNR844), Eyenovia (MicroLine), AbbVie (AGN-241622), Ocuphire Pharma (Nyxol), Visus therapeutics (Brimochol), and others, most of which are expected to launch during the forecast period [2022-2032]."
Presbyopia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Presbyopia Epidemiology Segmentation:
The Presbyopia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Presbyopia
• Prevalent Cases of Presbyopia by severity
• Gender-specific Prevalence of Presbyopia
• Diagnosed Cases of Episodic and Chronic Presbyopia
Presbyopia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Presbyopia market or expected to get launched during the study period. The analysis covers Presbyopia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Presbyopia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Discover more about therapies set to grab major Presbyopia market share @ Presbyopia market forecast
https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Presbyopia Therapies and Key Companies
• MicroLine: Eyenovia
• CSF-1: Orasis Pharmaceutical
• Nyxol: Ocuphire Pharma
• UNR844: Novartis
• VT-101/Brimochol: Visus Therapeutics
Presbyopia Market Drivers
• Rising prevalence of Presbyopia
• An upsurge in launch of products
• Increasing lifestyle changes
• Increasing research in pharmaceutical treatment
• Increase in geriatric population
Scope of the Presbyopia Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Presbyopia Companies: Eyenovia, Orasis Pharmaceutical, Ocuphire Pharma, Novartis, Visus Therapeutics, and others
• Key Presbyopia Therapies: MicroLine, CSF-1, Nyxol, UNR844, VT-101, Brimochol, and others
• Presbyopia Therapeutic Assessment: Presbyopia current marketed and Presbyopia emerging therapies
• Presbyopia Market Dynamics: Presbyopia market drivers and Presbyopia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Presbyopia Unmet Needs, KOL's views, Analyst's views, Presbyopia Market Access and Reimbursement
Presbyopia Market Barriers
• Rising healthcare costs
• Shortage of trained ophthalmologists
• Lack of accessibility of eye care services
• Limitations of Monovision
Table of Contents
1. Presbyopia Market Report Introduction
2. Executive Summary for Presbyopia
3. SWOT analysis of Presbyopia
4. Presbyopia Patient Share (%) Overview at a Glance
5. Presbyopia Market Overview at a Glance
6. Presbyopia Disease Background and Overview
7. Presbyopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Presbyopia
9. Presbyopia Current Treatment and Medical Practices
10. Presbyopia Unmet Needs
11. Presbyopia Emerging Therapies
12. Presbyopia Market Outlook
13. Country-Wise Presbyopia Market Analysis (2019-2032)
14. Presbyopia Market Access and Reimbursement of Therapies
15. Presbyopia Market Drivers
16. Presbyopia Market Barriers
17. Presbyopia Appendix
18. Presbyopia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Presbyopia treatment, visit @ Presbyopia Medications https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Presbyopia Pipeline https://www.delveinsight.com/report-store/presbyopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Presbyopia Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Presbyopia market. A detailed picture of the Presbyopia pipeline landscape is provided, which includes the disease overview and Presbyopia treatment guidelines.
Presbyopia Epidemiology https://www.delveinsight.com/report-store/presbyopia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Presbyopia Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Presbyopia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Trending Reports by DelveInsight
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Presbyopia Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies - Eyenovia, Orasis Pharmaceutical, Ocuphire Pharma, Novartis, Visus Therapeutics here
News-ID: 2769647 • Views: …
More Releases from DelveInsight Business Research
Autotransfusion Systems Market is Expected to Reach USD 816.35 million by 2032 | …
The global Autotransfusion Systems Market is witnessing steady growth as healthcare systems worldwide continue to prioritize patient safety, blood conservation, and advanced surgical efficiency. According to DelveInsight's latest report, the market was valued at USD 512.82 million in 2024 and is projected to reach USD 816.35 million by 2032, expanding at a CAGR of 6.04% during the forecast period (2025-2032).
Autotransfusion systems are gaining traction across hospitals and surgical centers due…
Global Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market t …
According to DelveInsight's latest report, "Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type, Power Source, End-User, and Geography," the global market is projected to grow at a steady compound annual growth rate (CAGR) of 5.36% during the forecast period from 2025 to 2032. The market, valued at USD 150.65 million in 2024, is anticipated to reach USD 227.88 million by 2032, driven by the increasing prevalence of cardiovascular…
Global Airway Management Devices Market is Expected to Reach USD 2.29 billion by …
The global Airway Management Devices Market is on a robust growth trajectory, projected to expand from USD 1.60 billion in 2023 to USD 2.29 billion by 2032, growing at a steady CAGR of 6.21% during the forecast period (2025-2032). The increasing prevalence of respiratory disorders such as asthma, COPD, and airway obstructions, along with a rise in surgical procedures and worsening air pollution, are among the primary factors fueling market…
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials …
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Cartilage Diseases companies are Regeneron, TissueGene, Vericel Corporation, Genzyme Corporation, Eli Lilly and Company, Incyte Corporation, Astellas Pharma, Pfizer, Sanofi, among others. Promising Cartilage Diseases therapies are Olumiant (Baricitinib), Celebrex (Celecoxib), Motrin (Ibuprofen), Kevzara (Sarilumab), and others.
DelveInsight's "Cartilage Diseases Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of…
More Releases for Presbyopia
Presbyopia Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Presbyopia Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the Presbyopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Presbyopia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Presbyopia…
Rising Geriatric Population Fuels Growth Of Myopia And Presbyopia Treatment Mark …
The Myopia and Presbyopia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Myopia and Presbyopia Treatment Market Size and Projected Growth Rate?
The market size for myopia and presbyopia treatment has witnessed substantial growth over several recent years. The market is projected…
Presbyopia Treatment Market Trends And Industry Forecast 2024-2031
Presbyopia Treatment Market: Trends Shaping the Industry
The presbyopia treatment market is experiencing significant growth, driven by a surge in the global aging population. As people live longer, the demand for effective solutions to age-related vision problems like presbyopia increases. This trend is fueling research and development efforts, leading to the introduction of innovative therapeutics like advanced contact lenses and eye drops.
Market Segmentation: Addressing Diverse Needs
The presbyopia treatment market is segmented…
Presbyopia Treatment Market Growth Analysis 2023-2030
Global Presbyopia Treatment Market Gains Momentum Amidst Rising Aging Population and Innovations in Therapeutics:
The global presbyopia treatment market has witnessed substantial growth in recent years, fueled by the increasing prevalence of presbyopia and the expanding aging population. Presbyopia, a common vision loss associated with aging, has prompted a surge in demand for effective treatments, leading to advancements in eyeglasses, contact lenses, surgeries, eye drops, and nutrient-based interventions.
Refractive surgeries, including Conductive…
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Presbyopia Pipeline Insight Report
• Presbyopia Pipeline report offers a comprehensive…
Presbyopia Market 2020-2027 Sets the Table for Continued Growth || Top Growing C …
A transparent research method has been accomplished with the right tools and techniques to make this Presbyopia Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter's Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint…
